Paid Clinical Trials in White Plains, NY
As of June 2026, 44 paid clinical trials are recruiting in White Plains, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
White Plains offers studies at sites including White Plains Hospital for conditions such as Aggression, Atrial Fibrillation, Autism Spectrum Disorder, Breast Cancer, Early Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in White Plains
Trials by drug in White Plains
Filter results
44 clinical trials
↓ Download CSVA Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
A Hybrid Program to Prevent Substance Use Risk Among Upper Elementary School Students Using a Positive Youth Development Approach
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Q Therapeutic System for Chronic Stroke Recovery
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Effects of Transcranial Random Noise Stimulation on Motor Learning in Typically Developing Adolescents
EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Study of ALTO-101 in Patients With Schizophrenia
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Mind-Body Skills Group for Graduate Students
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Observational Study Protocol: LIVER-R
Vivistim Registry for Paired VNS Therapy (GRASP)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy
GEMINI-NSCLC: NSCLC Biomarker Study
A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD
WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Pancreatic Cancer Early Detection Consortium
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
tDCS and Bimanual Therapy for Children With Hemiplegic Cerebral Palsy
About research studies in White Plains
White Plains has approximately 44 recruiting research studies across a wide range of therapeutic areas. New York is home to leading academic medical centers such as Memorial Sloan Kettering, Weill Cornell Medicine, Mount Sinai, NYU Langone, and Columbia University Irving Medical Center. These institutions anchor a research ecosystem that covers oncology, cardiology, neurology, and rare disease.
Top Research Study Locations in White Plains
Researchers run research studies in White Plains, NY at 17 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| White Plains Hospital | Acute Myeloid Leukemia, Atrial Fibrillation, Breast Neoplasms | 10 |
| Dickstein Cancer Treatment Center | Stage IIIB Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma, Advanced Lung Non-Squamous Non-Small Cell Carcinoma | 6 |
| Burke Rehabilitation Hospital | Apraxia of Speech, Brain Injury, Cerebrovascular Accident (CVA) | 4 |
| Burke Neurological Institute | Cerebral Palsy, Children, Spastic Cerebral Palsy | 2 |
| Center for Autism and the Developing Brain | Autism Spectrum Disorder, Aggression, Challenging Behaviour | 2 |
| White Plains Hospital Physician Associates | Limited Stage Small Cell Lung Cancer, Triple Negative Breast Cancer | 2 |
| Burke Medical Research Institute | Cerebral Palsy, Hemiplegic Cerebral Palsy, Spastic Hemiparesis | 1 |
| Burke Rehabilitation Center | Atrial Fibrillation, Intracerebral Hemorrhage | 1 |
| Local Institution - 0020 | Schizophrenia | 1 |
| Local Institution - 0618 | Carcinoma, Non-Small-Cell Lung | 1 |
| National Health Promotion Associates | E Cig Use, Prescription Drug Misuse, Vaping | 1 |
| NewYork-Presbyterian/Weill Cornell Medical Center Westchester Division | Aggression, Schizoaffecitve Disorder, Schizophrenia Disorder | 1 |
| Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine | Depression, Suicidal Ideation, Suicide, Attempted | 1 |
| Weill Cornell Medical College | Anxiety Generalized, Depressive Symptoms, Mood Change | 1 |
| Weill Cornell Medicine | Cognitive Impairment, Depression, Pain | 1 |
| White Plains Hospital Center for Cancer Care - Oncology | Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreatic Cancer | 1 |
| White Plains Hospital-Center for Cancer Care | Hematologic Malignancies, Solid Tumors | 1 |
Active & Upcoming Studies in White Plains (2026)
Recruiting trials in White Plains grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (23 active studies)
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. · Phase 2, Phase 3 · Eikon Therapeutics
- A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer · Phase 3 · Astellas Pharma Global Development, Inc.
Mental health & behavior (6 active studies)
- A Virtual Reality Mindfulness Application for Aggression in Schizophrenia · Manhattan Psychiatric Center
- Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) · Bristol-Myers Squibb
Neurology & pain (3 active studies)
- Q Therapeutic System for Chronic Stroke Recovery · Burke Rehabilitation Hospital
- EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment · BrainQ Technologies Ltd.
Cardiovascular (2 active studies)
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation · Phase 3 · Johns Hopkins University
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery · Phase 3 · Yale University
Pediatric (1 active study)
- Effects of Transcranial Random Noise Stimulation on Motor Learning in Typically Developing Adolescents · EARLY_Phase 1 · Burke Medical Research Institute
Common conditions studied in White Plains
- Aggression (2 active studies). Recruiting Aggression studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Atrial Fibrillation (2 active studies). Atrial fibrillation studies investigate next-generation anticoagulants, ablation technologies, and left atrial appendage closure devices.
- Autism Spectrum Disorder (2 active studies). Recruiting Autism Spectrum Disorder studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Cancer, Early Breast Cancer (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Cerebral Palsy (2 active studies). Recruiting Cerebral Palsy studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Cognitive Impairment (2 active studies). ENT (otolaryngology) trials evaluate new treatments for hearing loss, swallowing disorders, and head and neck cancers — covering pharmacologic, surgical, and rehabilitative approaches.
Leading research sponsors in White Plains
- AstraZeneca
- National Cancer Institute (NCI)
- Burke Medical Research Institute
- Weill Medical College of Cornell University
- BioNTech SE
Local regulations and guidelines
Clinical trials in New York are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials conducted in New York must also comply with the NY SHIELD Act's data-protection requirements and additional oversight from the New York State Department of Health.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in White Plains. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in White Plains
Hipa.ai aggregates every recruiting study in White Plains from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in White Plains?
There are approximately 44 recruiting clinical trials in White Plains, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in White Plains pay participants?
Most recruiting trials in White Plains compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in White Plains?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in White Plains?
The most common conditions under active study in White Plains include Aggression (2), Atrial Fibrillation (2), Autism Spectrum Disorder (2), Breast Cancer, Early Breast Cancer (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in White Plains?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in White Plains on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in White Plains?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in White Plains?
Recruiting research sites in White Plains include White Plains Hospital, Dickstein Cancer Treatment Center, Burke Rehabilitation Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in White Plains right now?
The largest active categories in White Plains are Cancer & tumors (23), Mental health & behavior (6), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.